Both in Pharmaceuticals
Akebia Therapeutics vs BridgeBio Oncology Therapeutics
Over the past year AKBA returned −66.1% and BBOT returned −80.8%; their daily moves had a correlation of 0.21.
AKBA −66.1% BBOT −80.8%Growth of $1, one year, split-adjusted
| Metric | AKBA | BBOT |
|---|---|---|
| Price | $0.7177 | $2.37 |
| Market cap | $198.9M | $189.6M |
| Today | +1.32% | +2.38% |
| 1 month | −21.2% | −34.3% |
| 6 months | −50.5% | −71.4% |
| Year to date | −55.4% | −81.1% |
| 1 year | −67.5% | −80.2% |
| Revenue growth (YoY) | −21.4% | — |
| Gross margin | 78.8% | — |
| Net margin | −18.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | $106.0M | $225.7M |
| Dividend yield | — | — |
| Volatility (60d) | 71.9% | 88.3% |
| Short % of float | 8.7% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).